Ratings by H.C. Wainwright (Emanuela Branchetti)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/23/2025 | BioCardiAa | BCDA | Maintain | Buy (Buy) |
|
Details | ||
| 7/2/2025 | Genenta Science S.p.A. | GNTA | Maintain | Buy (Buy) |
|
Details | ||
| 10/3/2024 | Genenta Science S.p.A. | GNTA | Maintain | Buy (Buy) |
|
Details | ||
| 8/14/2024 | BioCardiAa | BCDA | Maintain | Buy (N/A) |
|
Details | ||
| 9/7/2023 | BioCardiAa | BCDA | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2022 | Genenta Science S.p.A. | GNTA | New Coverage | Buy (N/A) |
6.74 (0.86) |
-87.24% | Details | |
| 3/30/2022 | BioCardiAa | BCDA | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2022 | Esperion Therapeutics | ESPR | New Coverage | Buy (N/A) |
4.57 (2.73) |
-40.26% | Details | |
| 12/20/2021 | BioCardiAa | BCDA | New Coverage | Buy (N/A) |
1.75 (1.18) |
-32.57% | Details |
